We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nervous System Defect Linked to Lipid Deficiency

By Biotechdaily staff writers
Posted on 12 Oct 2004
Researchers have found that synthesis of the membrane lipid phosphatidylinositol-4,5-bisphosphate (PtdIns[4,5]P2) in synaptic vesicles plays a critical role in the regulation of multiple steps of the synaptic vesicle cycle and ultimately in how messages are passed from the brain to the nervous system.

Investigators at Yale University (New Haven, CT, USA; www.yale.edu) worked with a line of mice that had been genetically engineered to lack the gene for the enzyme PIPK1-gamma in their synaptic vesicles. More...
This enzyme is required for the synthesis of PtdIns(4,5)P2.

Results published in the September 23, 2004, issue of Nature revealed that the mice with decreased PtdIns(4,5)P2 developed defective synaptic vesicles that led to their deaths shortly after birth. Defects included decreased frequency of miniature currents, enhanced synaptic depression, a smaller readily releasable pool of vesicles, delayed endocytosis, and slower recycling kinetics.

"This study is the first to show that lowering the levels of this lipid in nerve terminals affects the efficiency of neurotransmission,” said senior author Dr. Pietro De Camilli, professor of cell biology at Yale University. "Typically, studies of synaptic transmission have focused on membrane proteins. Only recently has the importance of the chemistry of membrane lipids and of their metabolism started to be fully appreciated. The field is still in its infancy, but rapid advancements in the methodology for the analysis of lipids promise major progress in the field and the possibility of identifying new targets for therapeutic interventions in human diseases.”



Related Links:
Yale University

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Aspiration System
VACUSAFE
New
POC Immunoassay Analyzer
Procise DX
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.